Cross-Border Licensing Agreements
1. Concept of Cross-Border Licensing Agreements
A cross-border licensing agreement is a legal contract in which a licensor in one country grants rights to a licensee in another country to use intellectual property (IP) such as:
Patents
Trademarks
Copyrights
Trade secrets
Designs
Key Features:
Territorial Scope: Rights and obligations are defined across countries.
Types of Licenses:
Exclusive: Only one licensee globally or in a specific region.
Non-exclusive: Licensor may license multiple parties.
Sole license: Licensor retains rights but grants one licensee.
Scope of Rights: Manufacturing, marketing, distribution, sublicensing.
Royalty/Payment Structure: Fixed fees, sales-based royalties, milestone payments.
Compliance with Laws: Must comply with local IP laws, competition law, and tax regulations.
Purpose:
Expand market reach without establishing operations abroad.
Monetize IP globally.
Protect IP rights while enabling local production or marketing.
2. Legal Considerations
Governing Law & Jurisdiction: Clearly stated in the contract.
IP Registration: Must be valid in the territories concerned.
Conflict of Law: Cross-border agreements may require arbitration clauses.
Competition Law: EU and US antitrust laws may restrict exclusive licensing.
Termination & Enforcement: Enforcement can be challenging across borders.
3. Landmark Cases in Cross-Border Licensing
Here are seven detailed cases illustrating cross-border licensing issues:
Case 1: Pfizer v. Teva (U.S. District Court, 2003)
Facts:
Pfizer licensed its drug patent rights to a foreign subsidiary, which sublicensed manufacturing to Teva in Israel. Teva intended to export the generic drug to the U.S.
Issue:
Whether the licensee had the right to manufacture abroad for export to the U.S., or if Pfizer could enforce patent rights under U.S. law.
Holding:
Court held that Pfizer’s license was territorial, and Teva’s export to the U.S. without authorization infringed Pfizer’s U.S. patent.
Significance:
Cross-border licensing agreements must clearly define territorial rights and export restrictions.
U.S. patent rights extend to unauthorized import of foreign-made products.
Case 2: Microsoft v. Motorola (U.S./EU, 2012)
Facts:
Motorola held SEPs (Standard Essential Patents) and licensed them to Microsoft for use in mobile devices sold in Europe and the U.S.
Issue:
Whether the license terms were FRAND (Fair, Reasonable, and Non-Discriminatory) across different jurisdictions.
Holding:
Courts in the U.S. and Germany confirmed that cross-border licensing must comply with FRAND obligations, balancing patent rights and competition law.
Significance:
Cross-border licensing of SEPs must respect global standards and antitrust regulations.
Courts may enforce license terms across multiple jurisdictions.
Case 3: Eli Lilly & Co. v. Hospira (U.S./Europe, 2014)
Facts:
Eli Lilly licensed patent rights for an oncology drug to a European manufacturer, which began exporting to countries not covered in the license.
Issue:
Whether cross-border export to non-licensed territories violated the licensing agreement.
Holding:
Court held that license scope is territorial, and unauthorized export amounted to breach of contract and patent infringement.
Significance:
Demonstrates the need for explicit territorial clauses in licensing agreements.
Cross-border enforcement requires both contract and IP law remedies.
Case 4: GlaxoSmithKline v. Apotex (UK, 2008)
Facts:
GSK licensed a patent for an HIV drug to a Canadian manufacturer, which tried to import into the UK market.
Issue:
Whether the license granted in Canada covered UK sales.
Holding:
UK High Court ruled that without explicit territorial rights, the licensee could not sell in the UK.
Significance:
Cross-border licenses must clearly specify permitted territories.
Courts enforce contractual terms strictly when territorial rights are ambiguous.
Case 5: BASF v. Monsanto (Germany, 2010)
Facts:
BASF sublicensed a patented herbicide from Monsanto for EU markets. Dispute arose regarding royalty payments based on sales outside Germany.
Issue:
Whether the royalty obligations applied to cross-border sales within the EU.
Holding:
German courts ruled that royalties applied only in territories expressly mentioned in the license agreement.
Significance:
Licensing agreements must define geographic scope of royalties.
Even within the EU single market, territorial clauses are legally significant.
Case 6: Qualcomm v. Nokia (EU/Global, 2013)
Facts:
Qualcomm licensed CDMA and LTE patents to Nokia with worldwide rights. Disputes arose regarding sublicenses and fees in multiple jurisdictions.
Issue:
Whether cross-border licensing obligations applied uniformly across countries.
Holding:
Courts confirmed that global licensing agreements must specify treatment of fees, sublicenses, and local compliance, or risk disputes.
Significance:
Highlights importance of detailed global licensing contracts.
Ensures enforcement of IP rights across jurisdictions.
Case 7: Bayer v. Watson (EU/US, 2015)
Facts:
Bayer licensed patent rights for a cardiovascular drug to Watson Labs. Watson exported generic versions to multiple countries outside the licensed territory.
Issue:
Whether unauthorized cross-border exports violated IP and licensing agreements.
Holding:
Courts ruled in favor of Bayer; licensees must adhere strictly to territorial and export clauses.
Significance:
Reinforces strict territorial enforcement in cross-border licensing.
Shows practical importance for compliance monitoring and auditing.
4. Key Takeaways
Territorial Clarity: Always define countries and markets covered.
Copying/Export Control: Licensees cannot export outside licensed territories without explicit permission.
Royalty & Fee Clauses: Must specify calculation methods for cross-border sales.
Compliance with Local Law: Consider IP, antitrust, and tax laws in each country.
Dispute Resolution: Arbitration clauses and choice of law are critical.
FRAND Obligations: Especially relevant for standard-essential patents.
Monitoring and Enforcement: Licensors must actively monitor compliance.
RELATED Blog
comments